Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-08-019114
Filing Date
2008-03-31
Accepted
2008-03-31 16:14:17
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 v108414_10k.htm 10-K 1357578
2 v108414_ex21-1.htm EX-21.1 2178
3 v108414_ex23-1.htm EX-23.1 4070
4 v108414_ex31-1.htm EX-31.1 18671
5 v108414_ex31-2.htm EX-31.2 18068
6 v108414_ex32-1.htm EX-32.1 7979
  Complete submission text file 0001144204-08-019114.txt   1410027
Mailing Address 221 WEST GRAND AVENUE MONTVALE, NJ 07645
Business Address 221 WEST GRAND AVENUE MONTVALE, NJ 07645 2019345000
Synvista Therapeutics, Inc. (Filer) CIK: 0000878903 (see all company filings)

EIN.: 133304550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16043 | Film No.: 08724759
SIC: 2834 Pharmaceutical Preparations